The Medicines Co (MDCO)

Add to Watchlists
Create an Alert
Quickflows
84.11 -0.11  -0.13% NASDAQ Dec 11, 11:34 Delayed 2m USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All MDCO News

News

View All Events

Events

Date Type Description
02/27/2020 08:30 EST Misc The Medicines Co Fourth Quarter Earnings Conference Call in 2019
02/27/2020 Earnings The Medicines Co Fourth Quarter Earnings in 2019 Release
10/30/2019 08:30 EDT Misc The Medicines Co Third Quarter Earnings Conference Call for 2019
10/30/2019 Earnings The Medicines Co Third Quarter Earnings in 2019 Release
07/24/2019 08:30 EDT Misc The Medicines Co Second Quarter Earnings Conference Call in 2019
07/24/2019 Earnings The Medicines Co Second Quarter Earnings in 2019 Release
05/30/2019 Misc The Medicines Co Annual General Meeting in 2018
04/25/2019 08:30 EDT Misc The Medicines Co First Quarter Earnings Conference Call in 2019
04/25/2019 Earnings The Medicines Co First Quarter Earnings in 2019 Release
02/27/2019 08:30 EST Misc The Medicines Co Fourth Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 14.73M
Total Expenses (TTM) 179.10M
Net Income (TTM) -236.39M

Balance Sheet View Statement

Total Assets (Quarterly) 897.27M
Total Liabilities (Quarterly) 923.27M
Shareholders Equity (Quarterly) -26.00M

Cash Flow Statement View Statement

Cash from Operations (TTM) -198.34M
Cash from Investing (TTM) 3.272M
Cash from Financing (TTM) 339.93M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.themedicinescompany.com
  • Investor Relations URL: http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-irhome
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 27, 2020
  • Last Earnings Release: Oct. 30, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 84.11
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
MNA IQ Merger Arbitrage ETF 7.32%
PHSRX Putnam Global Health Care R 4.70%
EAFRX First Eagle Fund of America R4 3.64%
HRSGX Harbor Small Cap Growth Admin 3.02%
TOECX Touchstone Mid Cap Growth C 2.79%
XBI SPDR® S&P Biotech ETF 2.55%
HGHVX Hartford Healthcare R6 1.70%
IJT iShares S&P Small-Cap 600 Growth ETF 1.26%
IBB iShares Nasdaq Biotechnology ETF 0.90%
IJR iShares Core S&P Small-Cap ETF 0.81%
VTSIX Vanguard Tax-Managed Small Cap I 0.51%
IWM iShares Russell 2000 ETF 0.31%

Comparables

Edit
ALNY Alnylam Pharmaceuticals Inc
AMGN Amgen Inc
CBAY CymaBay Therapeutics Inc
MRK Merck & Co Inc
AQST Aquestive Therapeutics Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.